Dr. Mark Kieran, director of pediatric medical neuro-oncology at Boston Children's Hospital and Dana Farber Cancer Insititute, is the principal investigator of the study.
The field of neuro-oncology is rapidly advancing and newer techniques and drugs appear to be increasing the length of time patients live after diagnosis.